{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:02:41Z","timestamp":1783702961915,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RDGS2024-04"],"award-info":[{"award-number":["RDGS2024-04"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["KF-202305"],"award-info":[{"award-number":["KF-202305"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271755"],"award-info":[{"award-number":["82271755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871230"],"award-info":[{"award-number":["81871230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113822","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T01:03:44Z","timestamp":1733792624000},"page":"113822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CD55 characterizes regulatory T cells with reduced functionality and is downregulated in rheumatoid arthritis"],"prefix":"10.1016","volume":"145","author":[{"given":"Ayibaota","family":"Bahabayi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-5626","authenticated-orcid":false,"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.intimp.2024.113822_b0005","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"9285","key":"10.1016\/j.intimp.2024.113822_b0010","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113822_b0015","article-title":"Function and Role of Regulatory T Cells in Rheumatoid Arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.intimp.2024.113822_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101359","article-title":"The Role of Regulatory T Cells in the Onset and Progression of Primary Sj\u00f6gren's Syndrome","volume":"12","author":"Blinova","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.intimp.2024.113822_b0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/08923973.2018.1437625","article-title":"CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis","volume":"40","author":"Safari","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113822_b0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1054\/bjoc.2000.1570","article-title":"CD55 is over-expressed in the tumour environment","volume":"84","author":"Li","year":"2001","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2024.113822_b0035","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1073\/pnas.0307200101","article-title":"Complement regulation at the molecular level: the structure of decay-accelerating factor","volume":"101","author":"Lukacik","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.intimp.2024.113822_b0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4049\/jimmunol.177.2.1070","article-title":"Costimulation via CD55 on human CD4+ T cells mediated by CD97","volume":"177","author":"Capasso","year":"2006","journal-title":"J Immunol"},{"issue":"5\u20136","key":"10.1016\/j.intimp.2024.113822_b0045","first-page":"223","article-title":"The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy","volume":"28","author":"Mikesch","year":"2006","journal-title":"Cell Oncol"},{"issue":"6","key":"10.1016\/j.intimp.2024.113822_b0050","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.4049\/jimmunol.149.6.2055","article-title":"Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells","volume":"149","author":"Finberg","year":"1992","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2024.113822_b0055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/rheumatology\/33.8.707","article-title":"Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis","volume":"33","author":"Jones","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"9","key":"10.1016\/j.intimp.2024.113822_b0060","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2024.113822_b0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-1-4939-9009-2_25","article-title":"Laboratory Guidelines for Animal Care","volume":"1920","author":"Couto","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.intimp.2024.113822_b0070","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.4049\/jimmunol.178.5.2961","article-title":"Regulatory T cells dynamically control the primary immune response to foreign antigen","volume":"178","author":"Haribhai","year":"2007","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2024.113822_b0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ni1445","article-title":"Regulatory T cell development in the absence of functional Foxp3","volume":"8","author":"Lin","year":"2007","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2024.113822_b0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.intimp.2024.113822_b0085","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.258932","article-title":"Physiological functions and roles in cancer of the proliferation marker Ki-67","volume":"135","author":"Andr\u00e9s-S\u00e1nchez","year":"2022","journal-title":"J Cell Sci"},{"key":"10.1016\/j.intimp.2024.113822_b0090","doi-asserted-by":"crossref","first-page":"1058763","DOI":"10.3389\/fimmu.2022.1058763","article-title":"Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids","volume":"13","author":"Gaykema","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2024.113822_b0095","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.4049\/jimmunol.1600631","article-title":"Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus","volume":"197","author":"Kwon","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113822_b0100","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.4110\/in.2018.18.e11","article-title":"Beyond the Role of CD55 as a Complement Component","volume":"18","author":"Dho","year":"2018","journal-title":"Immune Netw"},{"issue":"12","key":"10.1016\/j.intimp.2024.113822_b0105","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.1301458","article-title":"CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype","volume":"191","author":"Sutavani","year":"2013","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.intimp.2024.113822_b0110","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/art.20499","article-title":"CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid","volume":"50","author":"Van Amelsfort","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113822_b0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cellimm.2008.05.007","article-title":"CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis","volume":"253","author":"Han","year":"2008","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113822_b0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/immu.200390024","article-title":"Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis","volume":"33","author":"Cao","year":"2003","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.intimp.2024.113822_b0125","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg balance in patients with rheumatoid arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.intimp.2024.113822_b0130","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3899\/jrheum.110283","article-title":"CD4+CD25(high)CD127(low\/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis","volume":"38","author":"Kawashiri","year":"2011","journal-title":"J Rheumatol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:43:04Z","timestamp":1734655384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924023440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"alternative-id":["S1567576924023440"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113822","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD55 characterizes regulatory T cells with reduced functionality and is downregulated in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113822"}}